These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5. Kalapurakal JA, Perlman EJ, Seibel NL, Ritchey M, Dome JS, Grundy PE. Int J Radiat Oncol Biol Phys; 2013 Feb 01; 85(2):428-31. PubMed ID: 22658515 [Abstract] [Full Text] [Related]
8. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies. Breslow NE, Ou SS, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas PR, D'Angio GJ, Green DM. Cancer; 2004 Sep 01; 101(5):1072-80. PubMed ID: 15329918 [Abstract] [Full Text] [Related]
16. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5). Seibel NL, Chi YY, Perlman EJ, Tian J, Sun J, Anderson JR, Ritchey ML, Thomas PR, Miser J, Kalapurakal JA, Grundy PE, Green DM. Pediatr Blood Cancer; 2019 Jan 20; 66(1):e27450. PubMed ID: 30255545 [Abstract] [Full Text] [Related]
17. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D. J Clin Oncol; 1995 Jan 20; 13(1):124-33. PubMed ID: 7799012 [Abstract] [Full Text] [Related]